Background: Early diagnosis and therapy improves outcomes in heart failure with
| INTRODUC TI ON
Heart failure (HF) with severely reduced left ventricular ejection fraction (LVEF ≤35%; Owan et al., 2006) remains a major public health problem in the USA, with an average 5-year mortality of 50% due to pump failure or sudden cardiac death (Roger et al., 2004) .
Early diagnosis and initiation of pharmacologic therapy for left ventricular systolic dysfunction (LVSD) reduces morbidity and increases survival (Dargie, 2001; Jong, Yusuf, Rousseau, Ahn, & Bangdiwala, 2003; SOLVD Investigators et al., 1992) . Severely reduced LVEF is detected by cardiac imaging, mostly echocardiography, but due to practical and cost-effectiveness considerations, broad deployment of imaging tools for screening of asymptomatic patients in the community is not viable. Myocardial electrical remodeling is a consistent feature of the HF syndrome and manifests as abnormalities in the 12-lead electrocardiogram (ECG), reported in a variety of patient populations Davey, 2000; Goldberger, 1982; Ilkhanoff et al., 2012; Lund et al., 2013; Murkofsky et al., 1998; O'Neal et al., 2016; Opdahl et al., 2014; Pavri et al., 2008) .
However, published studies of the association between electrical remodeling with left ventricular (LV) dysfunction are relatively small and have focused mainly on a limited number of individual ECG variables, largely atrial fibrillation, left bundle branch block (LBBB), and ventricular pacing Davey, 2000; Goldberger, 1982; Ilkhanoff et al., 2012; Lund et al., 2013; Murkofsky et al., 1998; O'Neal et al., 2016; Opdahl et al., 2014; Pavri et al., 2008) . We hypothesized that a panel of additional specific, easily obtained ECG markers could identify a larger proportion of patients with severely reduced LVEF, and also distinguish these patients from those with preserved LVEF.
We evaluated the correlation of nine expanded ECG markers with LVEF ≤35% from the ongoing community-based Oregon Sudden Unexpected Death Study (Oregon SUDS) based in Portland, Oregon. Subsequently, we evaluated this association in a separate population from the Cedars-Sinai Health System in Los Angeles, California.
| ME THODS

| Discovery population
We examined the association of ECG risk markers with echocardiographically assessed LV function among participants in the ongoing Oregon SUDS. The methods and rationale of the Oregon SUDS have been described previously (Chugh et al., 2004; Narayanan et al., 2013) Briefly, the study prospectively identifies out-of-hospital sudden cardiac arrest (SCA) cases occurring in the Portland, OR metro area, and conducts comparisons with control subjects from the same geographic area. Clinical history for study participants, including cardiac tests and imaging, is obtained from available medical records. For this analysis, cardiac arrest cases and control subjects enrolled from 2002 to 2015 were pooled and included if they had LVEF assessed by echocardiography and an ECG available in existing medical records; if >1 echocardiogram or ECG was available, the one closest to arrest/ascertainment was obtained. For SCA cases, the ECG and echocardiogram were required to have been performed prior, and unrelated to the cardiac arrest event.
| Validation population
The association of LVEF ≤35% with myocardial electrical remodeling as measured by the expanded ECG panel was validated in a large, separate patient population from the Cedars-Sinai Health System (Los Angeles, CA). Patients with a transthoracic echocardiogram performed from January 1 to December 31, 2015 were retrospectively identified from the hospital's echocardiography laboratory database, and the most recent test was analyzed. LVEF was calculated using the biplane method of disk summation (modified Simpson's rule) based on left ventricular end-diastolic and end-systolic volumes measured in the apical two-and four-chamber views (Lang et al., 2015) . Patients with LVEF ≤35% were considered to have severely reduced LV systolic function.
Subsequently, the MUSE (GE Healthcare, Milwaukee, WI) electrocardiographic database management system and archive of all the ECGs recorded at the medical center was queried to obtain the digital ECG closest to the echocardiogram of each patient. Patients were included in this analysis if they were over 16 years old and had a resting 12-lead ECG performed within 14 days of the echocardiogram (67% of all patients with an echo had an ECG within 14 days).
The study was approved by the Institutional Review Boards of Cedars-Sinai Medical Center, Oregon Health and Science University, and all participating hospitals and health systems, and subjects provided informed consent as directed by these boards.
| ECG markers
The nine parameters of the expanded ECG panel were the following: heart rate, P-wave duration, PR interval, QRS duration, QTc interval (Bazett's correction), frontal QRS-T angle (calculated as the absolute difference between the frontal QRS axis and T-wave axis with values 0° ̶ 180°), delayed QRS transition zone (R-wave amplitude less than S-wave amplitude in lead V 4 ), delayed intrinsicoid deflection (defined as R-peak time ≥50 ms in lead V 5 or V 6 ), and left ventricular hypertrophy (LVH; by Cornell voltage or Sokolow-Lyon criteria).
In addition, the ECG was evaluated for rhythm, presence of LBBB, and acute ST-elevation myocardial infarction (MI). In the Oregon SUDS, we analyzed archived resting 12-lead ECGs with paper speed of 25 mm/s and calibration of 10 mm/mV, as previously described (Panikkath et al., 2011; Teodorescu et al., 2011) . QRS transition zone, intrinsicoid deflection, LVH, LBBB, and acute ST elevation MI were determined by manual review. At Cedars-Sinai, computerized measurements of all parameters were available from the digital ECG reports. Clinically over-read diagnoses were used to identify paced ECG rhythm, atrial fibrillation/flutter (AF), LVH, LBBB, and acute ST-elevation MI. The reliability, sensitivity, and specificity of these diagnostic algorithms have been previously demonstrated (Guglin & Thatai, 2006) . From the total ECGs available, we excluded ECGs with evidence of acute ST-elevation MI.
| Statistical methods
As a first step, we evaluated the association of ECG findings conventionally associated with LVEF that included ventricular pacing, AF, or presence of LBBB. In Oregon SUDS, we excluded ventricular paced ECGs a priori, and therefore, ventricular paced rhythms were not included in analyses of conventional ECG abnormalities.
Subsequently, we analyzed the remaining larger subset of patients without conventional ECG abnormalities, to examine associations between the expanded panel of 9 ECG markers and LVEF. We used chi-square tests for univariate associations, and automated stepwise logistic regression to test the multivariable-adjusted association of each ECG marker, with LVEF ≤35% as the outcome and the nine individual ECG markers as predictors. Potential collinearity was evaluated in both populations by calculating the variance in- heart rate >85 bpm; QRS duration >110 ms; QTc interval ≥460 ms for men and ≥470 ms for women; QRS-T angle >90°; PR interval >200 ms; and P-wave duration >110 ms. The remaining variables were dichotomous only: delayed QRS transition zone, delayed intrinsicoid deflection, and LVH.
| Summed expanded panel of abnormal ECG markers
Finally, in both populations we calculated a sum for the expanded abnormal ECG marker panel, in which each variable significant at p < 0.10 in either the continuous or categorical models was assigned one point (the unweighted panel). As a sensitivity analysis, Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for the expanded ECG panel. 95% CI 0.9-2.2). Among the remaining 830 subjects (423 cases, 407 controls) in sinus rhythm without conventional ECG abnormalities (16% with LVEF ≤35%), all ECG parameters were significantly associated with LVEF ≤35% in univariate comparisons (p ≤ 0.01). In multivariable models, heart rate, QRS duration, QRS-T angle, QRS transition zone, and PR-interval remained independently associated with LVEF ≤35%. In this subset, 12% of patients with LVEF ≤35% and 1% of patients with LVEF >35% had ≥4 of the abnormal ECG markers from the expanded panel (p < 0.001). When these ECG parameters were combined to construct the unweighted summed expanded ECG panel, a 1-unit increase in the panel sum was associated with 2.5-fold higher odds of LVEF ≤35% (OR 2.5; 95% CI 2.0-3.1; C-statistic 0.763). The weighted panel performed similarly (C-statistic 0.747).
| RE SULTS
| Oregon SUDS discovery population
| Cedars-Sinai validation population
A total of 9,742 consecutive patients (9.1% with LVEF ≤35%) had a transthoracic echocardiographic study performed between January 1 and December 31, 2015 at the Cedars-Sinai Medical Center, with a 12-lead ECG available within 14 days of the echocardiogram (same day in 62%, within 3 days in 93%). After excluding 68 patients with acute ST-elevation MI, 1,896 (20%) of the remaining 9,674 patients had at least one major ECG abnormality clinically accepted to be associated with HF: LBBB, AF, or paced rhythm. After further excluding 177 subjects with other arrhythmias or missing data, 7,601 subjects remained in the final analysis.
Among these patients, severely reduced LVEF ≤35% was present in 6.1%. Notes. Data are presented as n (%) or mean ± SD. All ECG parameters differed significantly between subjects with LVEF ≤35% and those with LVEF >35%.
a Validation population: n = 9,742 inpatients and outpatients from the Cedars-Sinai hospital system with LVEF assessed by echocardiogram from January 1 to December 31, 2015 and ECG available within 14 days of the echocardiogram. Conventional ECG abnormalities evaluated in n = 9,674 patients without acute myocardial infarction; expanded panel of ECG abnormalities evaluated in n = 7,601 patients without conventional abnormalities (ECGs in sinus rhythm and without LBBB).
| Conventional ECG abnormalities associated with reduced LV function
Major ECG abnormalities (AF, paced rhythms, or LBBB) were more common in patients with lower ejection fractions (Figure 1 
| Expanded panel of abnormal ECG markers associated with reduced ejection fraction
As in the discovery population, all nine of the expanded ECG parameters were associated with LVEF ≤35% in univariate comparisons in the validation cohort (p < 0.001) ( Table 1 ). In the multivariable model, heart rate, QTc interval, QRS duration, QRS-T angle, delayed QRS transition zone, and delayed intrinsicoid deflection remained independently associated with LVEF ≤35%, while LVH, prolonged PR interval, and prolonged P wave were not significant (Table 2) .
Based on the six statistically significant ECG markers, an unweighted expanded ECG panel sum was constructed ranging from 0 to ≥4 abnormal markers. A one-unit increase in the panel sum was associated with 2.9-fold increased odds of LVEF ≤35% (OR 2.9; 95% CI 2.6-3.1; C-statistic 0.831). The ORs remained consistent in models stratified by sex and age, ranging from 2.6 to 3.5. There was no significant interaction by sex with the ECG panel sum (p = 0.36).
The weighted panel sum, constructed as described in the Methods, ranged from 0 to 18, and had a dose-response increase in odds of LVEF ≤35%, with similar discrimination (C-statistic 0.845). Because the results were similar, we used the unweighted panel sum for further analysis.
The expanded ECG panel was significantly associated (p < 0.001) with decreasing LVEF in the validation population. Starting with the overall population, use of the expanded panel in addition to the conventional markers increased identification of abnormal ECG findings from 44% to 65% among patients with LVEF ≤35% (Figure 1 ).
Among the subset of patients without conventional ECG abnormalities (n = 7,601), 461 patients had LVEF ≤35%, and 184 (40%) of these had an expanded ECG panel sum of at least 4. The majority of patients without conventional ECG abnormalities had LVEF >35% (7,140 of 7,601, 94%), and among these, only 5% had a panel sum of ≥4. Conversely, 61% of the 7,601 patients had ≤1
abnormal markers, and among them, only 1.3% had LVEF ≤35%.
Among the 564 patients (7% of the total 7,601 patients) with an expanded ECG panel sum of ≥4, 184 (33%) had LVEF ≤35% 
| D ISCUSS I ON
To our knowledge, this is the first report of an expanded ECG marker panel that was consistently associated with severely reduced LVEF in two separate populations. We first identified a combination of ECG
ECG parameter
Initial model with all ECG parameters
Final model retaining parameters if p < 0.10 a
Odds ratio (95% CI) p-Value
Heart rate >85 bpm 1.9(1.5-2.3) <0.001 1.8 (1.5-2.2) <0.001
QRS >110 ms 1.3 (1.0-1.6) 0.06 1.3 (1.0-1.6) 0.04 QTc ≥460 ms men; ≥470 ms women 2.9 (2.3-3.6) <0.001 2.9 (2.3-3.6) <0.001
Delayed QRS transition 3.1 (2.5-3.9) <0.001 3.1 (2.5-3.9) <0.001 Published studies have reported a correlation between abnormal ECG diagnoses such as atrial fibrillation, LBBB, ventricular paced rhythms and reduced LVEF; and in clinical practice, these findings generally prompt clinicians to evaluate the LVEF (Baker, Bahler, Finkelhor, & Lauer, 2003; Davie et al., 1996; Nielsen, Hansen, Hilden, Larsen, & Svanegaard, 2000; Olesen & Andersen, 2016; Rihal, Davis, Kennedy, & Gersh, 1995; Talreja, Gruver, Sklenar, Dent, & Kaul, 2000) . Our results are also consistent with these established findings. However, a large subgroup of patients will have reduced LVEF in the absence of these conventionally accepted ECG markers (Baker et al., 2003; Olesen & Andersen, 2016) . As a consequence, there is substantial room for improvement for identification of patients with severely reduced LVEF.
Therefore, we examined an expanded panel of abnormal ECG markers that are not currently considered as indicators of LVSD in clinical practice. The association between several individual ECG markers and LVSD has been previously reported. For example, increased resting heart rate has been associated with reduced LVEF even in asymptomatic individuals in the general population (Opdahl et al., 2014) . Several studies among HF patients and other populations have linked QRS prolongation with decreased LV systolic function (Ilkhanoff et al., 2012; Lund et al., 2013; Murkofsky et al., 1998) .
However, early attempts to directly estimate LV function using measures of QRS morphology from the ECG had limited success (Young, Abouantoun, Savvides, Madsen, & Froelicher, 1983) . The more-specific depolarization measures included in the expanded panel, that is, delayed intrinsicoid deflection (Darouian et al., 2016; O'Neal et al., 2016) and QRS transition zone (Aro et al., 2017) , were individually associated with low LVEF. In addition, prolonged QTc-interval and wide QRS-T angle have been associated with LV dysfunction (Davey, 2000; Pavri et al., 2008) . However, to our knowledge, these ECG markers have not been previously combined to examine their joint association with LVSD.
In our validation study population, after excluding patients with major ECG abnormalities conventionally associated with HF, 7.4% of patients had ≥4 abnormal ECG findings, and one-third of these patients had evidence of severe LVSD. In this heterogeneous population, positive and negative predictive values of having ≥4 abnormal ECG markers were higher than those of the traditional major ECG abnormalities (Lieberman, 2010) . Furthermore, 60% of the patients had only 0-1 ECG abnormalities, and in this group, the prevalence of LVEF ≤35% was under 1.5%. This observation, in accordance with previous reports (Nielsen et al., 2000) , suggests that a normal ECG virtually excludes severe LVSD. Together, these findings imply that a markedly abnormal electrical profile, even in the absence of other conventionally used major ECG abnormalities, is strongly correlated with LV systolic function.
There are several factors that could explain the relationship between increasing number of ECG abnormalities and decreased LVEF. Pathologic LV remodeling in ischemic or nonischemic cardiomyopathy has electrical components that are reflected as abnormalities in cardiac conduction and myocardial depolarization/repolarization markers (Davey, 2000; Ilkhanoff et al., 2012) . As highlighted recently , structural and electrical remodeling contribute independently to risk of morbidity and mortality. Another established manifestation of the HF syndrome is abnormal autonomic remodeling, reflected by increased resting heart rate (Floras, 2009; Opdahl et al., 2014) .
| Study limitations
The strengths of this study lie in discovery and validation of an expanded panel of abnormal ECG markers and LVEF in two separate populations, and in the large size of the validation population.
However, some potential limitations should be considered while interpreting these findings. As the analysis was restricted to subjects undergoing echocardiographic examination, these could represent a subgroup of patients with higher morbidity. In addition, the overall prevalence of LVSD was relatively high: 16% in the Oregon SUDS population (a population enriched for SCA cases and coronary disease), and 9% in our validation study population of largely hospitalized patients. Although the consistency of associations between ECG parameters and LVEF in these two very different populations is encouraging, nonetheless these results may not be generalizable to the general population or to a purely out-patient population.
However, among a combination of outpatient and hospitalized patients, a set of relatively easily obtained ECG markers was strongly correlated with severe LVSD (Galasko, Barnes, Collinson, Lahiri, & Senior, 2006) .
| CON CLUS IONS
A panel of multiple, broadly available ECG markers was strongly associated with findings of severely reduced LV systolic function. 
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